Former Theranos chief’s fate hangs in balance as jurors deliberate verdict for a 4th day

THE jury in the trial against former Theranos CEO Elizabeth Holmes has entered its second week of deliberations. In March 2018, the US Securities and Exchange Commission charged Holmes and Theranos’s former president, Ramesh Balwani, with fraud by taking more than $700million from investors while advertising a false product. Theranos, a Silicon Valley biotech company, was once valued at $10billion and claimed to have created groundbreaking medical testing equipment. The diagnostics company promised faster and cheaper results than traditional labs, running an analytical gamut with a few drops of blood. However, after years of hype and billions of dollars later,… Read Full Article